EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Pre‐Post Assessment of Blood Glucose Control Following Pharmacist‐Led Professional Continuous Glucose Monitoring in Rhode Island Primary Care Practices

Kelley Doherty Sanzen, Natalya S Salganik, Susanne M Campbell, Carolyn A Karner, Pano M Yeracaris iD, Stephen J Kogut iD

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2026

DOI: 10.1002/jac5.70171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2026. Verfasst von Kelley Doherty Sanzen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Care Transformation Collaborative of RI, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Blood Glucose, Pharmacists, Glycemic Control, Diabetes Mellitus. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Healthcare, Rhode Island Department of Health, State of Rhode Island Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Professional continuous glucose monitoring (proCGM) can improve glycemic control and support medication and lifestyle adjustments in people with diabetes. In 2022, the Care Transformation Collaborative of Rhode Island launched a quality improvement initiative to implement pharmacist‐led proCGM services in primary care practices. This project aimed to determine the effects of a pharmacist‐led proCGM service on glycemic control, overall and by practice site, compared to baseline hemoglobin A1C (A1C) level. A secondary aim was to assess care team members' views of the program impact on patients and the practice environment.

Methods

A pre‐post design was employed to assess reduction in A1C level 6 months following the implementation of pharmacist‐led proCGM at six primary care sites. Pharmacists placed sensors, interpreted CGM data, and initiated diabetes medication changes. Eligible adult patients had either suboptimal glycemic control, discordant A1C and self‐monitoring data, high hypoglycemia risk, or were referred by a provider. Changes in A1C were assessed 3–6 months after proCGM use. Care team surveys captured perceptions of the program's impact and sustainability.

Results

Among 396 patients, mean A1C decreased from 9.36% to 8.25% ( p < 0.0001). A ≥ 1% point A1C reduction was achieved in 45.2% of patients. In multivariable analysis, baseline A1C was the strongest predictor of A1C improvement. Patients not using insulin and those who adopted personal CGM after the intervention were also more likely to improve. The majority of 51 care team members who completed the survey strongly agreed the service had positive impacts on patients and staff, and a majority believed the service could be sustainable.

Conclusion

Pharmacist‐led proCGM services were associated with meaningful short‐term A1C reductions, especially in patients with high baseline A1C not using insulin. The model was well‐received by care teams and may help expand access to effective diabetes management in primary care settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucosePharmacistsGlycemic ControlDiabetes MellitusHumansContinuous Glucose MonitoringRhode IslandPrimary Health CareGlycated HemoglobinFemaleMaleMiddle AgedAgedProfessional RoleBlood Glucose Self-MonitoringHypoglycemic Agents

Stichwörter der Autor:innen

continuous glucose monitoringdiabetes mellitusglucosepharmacist

Substanzen

Glycated HemoglobinBlood Glucosehemoglobin A1c protein, humanHypoglycemic Agents

Autor:innen und Institutionen

  • Care Transformation Collaborative of RI, Providence, Rhode Island, USA.
  • Division of Kidney Disease and Hypertension, Brown Medicine, Providence, Rhode Island, USA.
  • Department of Pharmacy Practice and Clinical Research, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.

ORCID-Profile: Pano M Yeracaris, Stephen J Kogut

Förderung

  • United Healthcare
  • Rhode Island Department of Health
  • State of Rhode Island Department of Health

Zitieren

APA

Sanzen, K. D., Salganik, N. S., Campbell, S. M., Karner, C. A., Yeracaris, P. M., & Kogut, S. J. (2026). A Pre‐Post Assessment of Blood Glucose Control Following Pharmacist‐Led Professional Continuous Glucose Monitoring in Rhode Island Primary Care Practices. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. https://doi.org/10.1002/jac5.70171

Vancouver

Sanzen KD, Salganik NS, Campbell SM, Karner CA, Yeracaris PM, Kogut SJ. A Pre‐Post Assessment of Blood Glucose Control Following Pharmacist‐Led Professional Continuous Glucose Monitoring in Rhode Island Primary Care Practices. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2026. doi:10.1002/jac5.70171

BibTeX
@article{Sanzen2026,
  author = {Sanzen, Kelley Doherty and Salganik, Natalya S and Campbell, Susanne M and Karner, Carolyn A and Yeracaris, Pano M and Kogut, Stephen J},
  title = {A Pre‐Post Assessment of Blood Glucose Control Following Pharmacist‐Led Professional Continuous Glucose Monitoring in Rhode Island Primary Care Practices},
  journal = {JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY},
  year = {2026},
  doi = {10.1002/jac5.70171}
}
Kostenlos starten →